Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Osteodex in CRPC with Skeletal Metastases
NCT02825628Phase 2Completed
- Sponsor
- DexTech Medical
- Start
- May 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of OsteoDex in castration-resistant prostate cancer (CRPC), sponsored by DexTech Medical. Started May 2016; status: completed.
02
Drugs
OsteoDex
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT02825628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02825628.